Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, announced the close of an approximately $15 million (approximately ¥1.4 billion) Series C financing.... Read more
Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients for... Read more
Singapore: Eisai has revealed therapeutic effects of lenvatinib (generic name- VEGF receptor tyrosine kinase inhibitor and... Read more
Singapore: Australia and Indonesia are jointly working towards the research to understand prevalence of AIDS and cancer in Indonesia, share... Read more
Singapore: GIDEON (Global Investigation of therapeutic Decisions in hepatocellular carcinoma and of its treatment with sorafenib) study... Read more
Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer contract manufacturing... Read more
Singapore: European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for... Read more
Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule pan-HER inhibitor,... Read more
Singapore: Novo Nordisk's 56-week double-blind phase IIIa clinical trial with liraglutide has shown that it has the potential to induce... Read more
Singapore: Johnson & Johnson (J&J) is contemplating the thought of treating depression using popular street drug ketamine, in what is being... Read more
Singapore: Merck, known as Merck Sharp & Dohme (MSD) outside the US and Canada, provided update on its clinical program for preladenant... Read more
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Japanese patent for... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
